These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 9689449)
1. Downregulation of oxidative phosphorylation in Alzheimer disease: loss of cytochrome oxidase subunit mRNA in the hippocampus and entorhinal cortex. Chandrasekaran K; Hatanpää K; Brady DR; Stoll J; Rapoport SI Brain Res; 1998 Jun; 796(1-2):13-9. PubMed ID: 9689449 [TBL] [Abstract][Full Text] [Related]
2. Decreased expression of N-methyl-D-aspartate receptor 1 messenger RNA in select regions of Alzheimer brain. Ulas J; Cotman CW Neuroscience; 1997 Aug; 79(4):973-82. PubMed ID: 9219960 [TBL] [Abstract][Full Text] [Related]
3. Localization of cytochrome oxidase (COX) activity and COX mRNA in the hippocampus and entorhinal cortex of the monkey brain: correlation with specific neuronal pathways. Chandrasekaran K; Stoll J; Brady DR; Rapoport SI Brain Res; 1992 May; 579(2):333-6. PubMed ID: 1320986 [TBL] [Abstract][Full Text] [Related]
4. N-methyl-D-aspartate receptor subunit NR2A and NR2B messenger RNA levels are altered in the hippocampus and entorhinal cortex in Alzheimer's disease. Bi H; Sze CI J Neurol Sci; 2002 Aug; 200(1-2):11-8. PubMed ID: 12127670 [TBL] [Abstract][Full Text] [Related]
5. Glutamatergic receptor expression changes in the Alzheimer's disease hippocampus and entorhinal cortex. Yeung JHY; Walby JL; Palpagama TH; Turner C; Waldvogel HJ; Faull RLM; Kwakowsky A Brain Pathol; 2021 Nov; 31(6):e13005. PubMed ID: 34269494 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA Expression in the Locus Coeruleus, Entorhinal Cortex, and Hippocampus at Early and Middle Stages of Braak Neurofibrillary Tangle Pathology. Llorens F; Thüne K; Andrés-Benito P; Tahir W; Ansoleaga B; Hernández-Ortega K; Martí E; Zerr I; Ferrer I J Mol Neurosci; 2017 Oct; 63(2):206-215. PubMed ID: 28871468 [TBL] [Abstract][Full Text] [Related]
7. Functional alterations in Alzheimer's disease: selective loss of mitochondrial-encoded cytochrome oxidase mRNA in the hippocampal formation. Simonian NA; Hyman BT J Neuropathol Exp Neurol; 1994 Sep; 53(5):508-12. PubMed ID: 8083692 [TBL] [Abstract][Full Text] [Related]
8. The loss of GluR2(3) immunoreactivity precedes neurofibrillary tangle formation in the entorhinal cortex and hippocampus of Alzheimer brains. Ikonomovic MD; Mizukami K; Davies P; Hamilton R; Sheffield R; Armstrong DM J Neuropathol Exp Neurol; 1997 Sep; 56(9):1018-27. PubMed ID: 9291943 [TBL] [Abstract][Full Text] [Related]
9. Expression of amyloid precursor protein, tau and presenilin RNAs in rat hippocampus following deafferentation lesions. Ramirez MJ; Heslop KE; Francis PT; Rattray M Brain Res; 2001 Jul; 907(1-2):222-32. PubMed ID: 11430905 [TBL] [Abstract][Full Text] [Related]
10. Increased apolipoprotein E mRNA in the hippocampus in Alzheimer disease and in rats after entorhinal cortex lesioning. Zarow C; Victoroff J Exp Neurol; 1998 Jan; 149(1):79-86. PubMed ID: 9454617 [TBL] [Abstract][Full Text] [Related]
11. No association between Alzheimer plaques and decreased levels of cytochrome oxidase subunit mRNA, a marker of neuronal energy metabolism. Hatanpää K; Chandrasekaran K; Brady DR; Rapoport SI Brain Res Mol Brain Res; 1998 Aug; 59(1):13-21. PubMed ID: 9729244 [TBL] [Abstract][Full Text] [Related]
12. Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. Price JL; Ko AI; Wade MJ; Tsou SK; McKeel DW; Morris JC Arch Neurol; 2001 Sep; 58(9):1395-402. PubMed ID: 11559310 [TBL] [Abstract][Full Text] [Related]
13. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Devanand DP; Pradhaban G; Liu X; Khandji A; De Santi S; Segal S; Rusinek H; Pelton GH; Honig LS; Mayeux R; Stern Y; Tabert MH; de Leon MJ Neurology; 2007 Mar; 68(11):828-36. PubMed ID: 17353470 [TBL] [Abstract][Full Text] [Related]
14. Alzheimer-related tau-pathology in the perforant path target zone and in the hippocampal stratum oriens and radiatum correlates with onset and degree of dementia. Thal DR; Holzer M; Rüb U; Waldmann G; Günzel S; Zedlick D; Schober R Exp Neurol; 2000 May; 163(1):98-110. PubMed ID: 10785448 [TBL] [Abstract][Full Text] [Related]
15. Reelin-immunoreactive neurons in entorhinal cortex layer II selectively express intracellular amyloid in early Alzheimer's disease. Kobro-Flatmoen A; Nagelhus A; Witter MP Neurobiol Dis; 2016 Sep; 93():172-83. PubMed ID: 27195475 [TBL] [Abstract][Full Text] [Related]
16. G-protein alpha-subunit levels in hippocampus and entorhinal cortex of brains staged for Alzheimer's disease neurofibrillary and amyloid pathologies. García-Jiménez A; Fastbom J; Ohm TG; Cowburn RF Neuroreport; 2003 Aug; 14(11):1523-7. PubMed ID: 12960778 [TBL] [Abstract][Full Text] [Related]
17. Loss of dopamine D2 receptors varies along the rostrocaudal axis of the hippocampal complex in Alzheimer's disease. Ryoo HL; Joyce JN J Comp Neurol; 1994 Oct; 348(1):94-110. PubMed ID: 7814686 [TBL] [Abstract][Full Text] [Related]
18. Neuronal activity and early neurofibrillary tangles in Alzheimer's disease. Hatanpää K; Brady DR; Stoll J; Rapoport SI; Chandrasekaran K Ann Neurol; 1996 Sep; 40(3):411-20. PubMed ID: 8797530 [TBL] [Abstract][Full Text] [Related]
19. Synapse alterations in the hippocampal-entorhinal formation in Alzheimer's disease with and without Lewy body disease. Wakabayashi K; Honer WG; Masliah E Brain Res; 1994 Dec; 667(1):24-32. PubMed ID: 7895080 [TBL] [Abstract][Full Text] [Related]
20. Selective deposition of amyloid-beta protein in the entorhinal-dentate projection of a transgenic mouse model of Alzheimer's disease. Su Y; Ni B J Neurosci Res; 1998 Jul; 53(2):177-86. PubMed ID: 9671974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]